Issue 16 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Beckerle ousted at Huntsman Cancer Institute as University of Utah asserts control over center's funds;

Huntsman: “Dr. Beckerle will be back in a few weeks.”

Huntsman Cancer Foundation: “We are asking the University of Utah to reinstate Dr. Beckerle”

FDA: “Rational” expansion of eligibility criteria for clinical trials would accelerate drug development

Cancer groups endorse March for Science

NCCN survey: AHCA would impede overall access to cancer treatment

In Brief

NCCS announces Ellen Stovall Award for Innovation in Patient-Centered Cancer Care

Luis Diaz to lead MSKCC Division of Solid Tumor Oncology

MD Anderson, Lion Biotechnologies to conduct clinical trials of TILs in multiple solid tumors

NCCN adds nine disease sites to its Radiation Therapy Compendium

Drugs & Targets

Tecentriq receives accelerated approval as initial treatment for advanced bladder cancer

CTL019 receives breakthrough designation for treatment of diffuse large B-cell lymphoma

Health Canada approves Darzalex for treatment of multiple myeloma

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login